Progressive respiratory failure in paraneoplastic pemphigus associated with chronic lymphocytic leukemia

Dermatology

Volumn 208, Issue 3, 2004, Pages 251-254

  Bronnimann M ^a,b   Von Felbert, V ^a   Streit, M ^a   Hunziker, T ^a   Braathen, L R ^a  

^a PSI   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Chronic lymphocytic leukemia; Erosive stomatitis; Exanthematic lichen planus; Paraneoplastic pemphigus; Respiratory failure

Indexed keywords

CHLORAMBUCIL; FLUDARABINE; HEPARIN; IMMUNOGLOBULIN; MITOXANTRONE; PREDNISOLONE; THEOPHYLLINE;

AGED; CANCER CHEMOTHERAPY; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE ASSOCIATION; DOSE RESPONSE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN DEPOSITION; LABORATORY TEST; MALE; PARANEOPLASTIC PEMPHIGUS; PARANEOPLASTIC SYNDROME; PEMPHIGUS; PRIORITY JOURNAL; RESPIRATORY FAILURE; TREATMENT OUTCOME;

AGED; FATAL OUTCOME; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; PARANEOPLASTIC SYNDROMES; PEMPHIGUS; RESPIRATORY INSUFFICIENCY;

EID: 2342462196     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077312     Document Type: Conference Paper

References (22)

1. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, et al: Paraneoplastic pemphigus: An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990;323:1729-1735.
2. Anhalt GJ: Paraneoplastic pemphigus. Adv Dermatol 1997;12:77-96.
3. Oursler JR, Labib RS, Ariss-Abdo L, Burke T, O'Keefe EJ, Anhalt GJ: Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Invest 1992;89:1775-1782.
4. Kim SC, Kwon YD, Lee IJ, Chang SN, Lee TG: cDNA cloning of the 210-kDa paraneoplastic pemphigus antigen reveals that envoplakin is a component of the antigen complex. J Invest Dermatol 1997;109:365-369.
5. Mahoney MG, Aho S, Uitto J, Stanley JR: The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol 1998;111:308-313.
6. Amagai M, Nishikawa T, Nousari HC, Anhalt GJ, Hashimoto T: Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest 1998;102:775-782.
7. Nousari HC, Deterding R, Wojtczack H, Aho S, Uitto J, Hashimoto T, et al: The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med 1999;340:1406-1410.
8. Mimouni D, Anhalt GJ, Lazarova Z, Aho S, Kazerounian S, Kouba DJ, et al: Paraneoplastic pemphigus in children and adolescents. Br J Dermatol 2002;147:725-732.
9. De Bruin A, Muller E, Wyder M, Anhalt GJ, Lemmens P, Suter MM: Periplakin and envoplakin are target antigens in canine and human paraneoplastic pemphigus. J Am Acad Dermatol 1999;40:682-685.
10. Camisa C, Helm TN: Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease. Arch Dermatol 1993;129:883-886.
11. Bialy-Golan A, Brenner S, Anhalt GJ: Paraneoplastic pemphigus: Oral involvement as the sole manifestation. Acta Derm Venereol 1996;76:253-254.
12. Krunic AL, Kokai D, Bacetic B, Kesic V, Nikolic MM, Petkovic S, et al: Retroperitoneal round-cell liposarcoma associated with paraneoplastic pemphigus presenting as lichen planus pemphigoides-like eruption. Int J Dermatol 1997;36:526-529.
13. Bowen GM, Peters NT, Fivenson DP, Su LD, Nousari HC, Anhalt GJ, et al: Lichenoid dermatitis in paraneoplastic pemphigus: A pathogenic trigger of epitope spreading? Arch Dermatol 2000;136:652-656.
14. Helou J, Allbritton J, Anhalt GJ: Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 1995;32:441-447.
15. Franke WW, Moll R, Schiller DL, Schmid E, Kartenbeck J, Mueller H: Desmoplakins of epithelial and myocardial desmosomes are immunologically and biochemically related. Differentiation 1982;23:115-127.
16. Inaoki M, Kodera M, Fujimoto A, Nousari HC, Anhalt GJ, Takehara K: Paraneoplastic pemphigus without antidesmoglein 3 or antidesmoglein 1 autoantibodies. Br J Dermatol 2001;144:610-613.
17. Mehregan DR, Oursler JR, Leiferman KM, Muller SA, Anhalt GJ, Peters MS: Paraneoplastic pemphigus: A subset of patients with pemphigus and neoplasia. J Cutan Pathol 1993;20:203-210.
18. Kirsner RS, Anhalt GJ, Kerdel FA: Treatment with alpha interferon associated with the development of paraneoplastic pemphigus. Br J Dermatol 1995;132:474-478.
19. Fried R, Lynfield Y, Vitale P, Anhalt G: Paraneoplastic pemphigus appearing as bullous pemphigoid-like eruption after palliative radiation therapy. J Am Acad Dermatol 1993;29:815-817.
20. Nousari HC, Brodsky RA, Jones RJ, Grever MR, Anhalt GJ: Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: Report of a case and review of this new therapy for severe autoimmune disease. J Am Acad Dermatol 1999;40:750-754.
21. Becker LR, Bastian BC, Wesselmann U, Karl S, Hamm H, Brocker EB: Paraneoplastic pemphigus treated with dexamethasone/cyclophosphamide pulse therapy. Eur J Dermatol 1998;8:551-553.
22. Borradori L, Lombardi T, Samson J, Girardet C, Saurat JH, Hugli A: Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus. Arch Dermatol 2001;137:269-272.